Highlights
AMEX: MTNB       Matinas Biopharma Hl
Last Price Today's Change   Day's Range   Trading Volume
1.56   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):9,352,383
4 Weeks Range:0.85 - 2.22
4 Weeks Price Volatility (%):
70.27%
52 Weeks Range:0.49 - 2.22
52 Weeks Price Volatility (%):
70.27%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Matinas BioPharma Holdings Inc is a US-based clinical-stage biopharmaceutical company which focuses on developing anti-infectives for orphan indications. The company's lead product candidate MAT2203 is an orally-administered cochleate formulation of a broad spectrum anti-fungal drug called amphotericin B and other clinical stage product candidate is MAT2501 which is a an orally administered, encochleated formulation of the broad spectrum aminoglycoside antibiotic amikacin which treats different types of multidrug-resistant bacteria, including non-tuberculous mycobacterium infections as well as various multidrug-resistant gram negative and intracellular bacterial infections.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2878  3560  211  3248 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AMC 4.42+0.91 
 BB 18.03+3.99 
 EXPR 4.15+2.36 
 NOK 4.85+0.65 
 SNDL 0.60-0.045 
 PLTR 36.23+3.65 
 CTRM 0.381-0.024 
 GME 76.79+11.78 
 LK 1.38+1.38 
 AAPL 142.92+3.85